215 related articles for article (PubMed ID: 19419768)
41. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
[TBL] [Abstract][Full Text] [Related]
42. Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis.
Zhang YN; Gao YY; Yang SD; Cao BB; Zheng KL; Wei P; Chen LF; Chen WX
BMC Neurol; 2019 Dec; 19(1):320. PubMed ID: 31830942
[TBL] [Abstract][Full Text] [Related]
43. Screening of genomic DNA to identify mutations in the gene for Bruton's tyrosine kinase.
Conley ME; Fitch-Hilgenberg ME; Cleveland JL; Parolini O; Rohrer J
Hum Mol Genet; 1994 Oct; 3(10):1751-6. PubMed ID: 7849697
[TBL] [Abstract][Full Text] [Related]
44. Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia.
Gray DH; Villegas I; Long J; Santos J; Keir A; Abele A; Kuo CY; Kohn DB
CRISPR J; 2021 Apr; 4(2):191-206. PubMed ID: 33876953
[TBL] [Abstract][Full Text] [Related]
45. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
[TBL] [Abstract][Full Text] [Related]
46. A Novel
Han SP; Lin YF; Weng HY; Tsai SF; Fu LS
Front Immunol; 2019; 10():1953. PubMed ID: 31481959
[TBL] [Abstract][Full Text] [Related]
47. Bruton's tyrosine kinase expression and activity in X-linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLA.
Gaspar HB; Lester T; Levinsky RJ; Kinnon C
Clin Exp Immunol; 1998 Feb; 111(2):334-8. PubMed ID: 9486400
[TBL] [Abstract][Full Text] [Related]
48. A novel BTK gene mutation creates a de-novo splice site in an X-linked agammaglobulinemia patient.
Chear CT; Ripen AM; Mohamed SA; Dhaliwal JS
Gene; 2015 Apr; 560(2):245-8. PubMed ID: 25680287
[TBL] [Abstract][Full Text] [Related]
49. Identification of a new Bruton's tyrosine kinase (BTK) mutation associated with a mild phenotype in a child with X-linked agammaglobulinemia (XLA).
Staehelin F; Kühne T
Clin Lab Haematol; 2000 Apr; 22(2):123-5. PubMed ID: 10792406
[TBL] [Abstract][Full Text] [Related]
50. Clinical manifestations and BTK gene defect in 4 unrelated Taiwanese families with Bruton's disease.
Lee KH; Shyur SD; Chu SH; Huang LH; Kao YH; Lei WT; Cheng CH; Lo CY; Chen CK; Liu LC
Asian Pac J Allergy Immunol; 2011 Sep; 29(3):260-5. PubMed ID: 22053596
[TBL] [Abstract][Full Text] [Related]
51. Genomic organization of the Btk gene and exon scanning for mutations in patients with X-linked agammaglobulinemia.
Hagemann TL; Chen Y; Rosen FS; Kwan SP
Hum Mol Genet; 1994 Oct; 3(10):1743-9. PubMed ID: 7880320
[TBL] [Abstract][Full Text] [Related]
52. Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X-linked agammaglobulinaemia patients.
Orlandi P; Ritis K; Moschese V; Angelini F; Arvanitidis K; Speletas M; Sideras P; Plebani A; Rossi P
Hum Mutat; 2000 Jan; 15(1):117. PubMed ID: 10612838
[TBL] [Abstract][Full Text] [Related]
53. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
Vihinen M; Brandau O; Brandén LJ; Kwan SP; Lappalainen I; Lester T; Noordzij JG; Ochs HD; Ollila J; Pienaar SM; Riikonen P; Saha BK; Smith CI
Nucleic Acids Res; 1998 Jan; 26(1):242-7. PubMed ID: 9399844
[TBL] [Abstract][Full Text] [Related]
54. Molecular analysis of Bruton's tyrosine kinase gene in Spain.
Rodríguez MC; Granados EL; Cerdán AF; Casariego GF
Hum Mutat; 2001; 18(1):84. PubMed ID: 11438999
[TBL] [Abstract][Full Text] [Related]
55. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection.
Futatani T; Miyawaki T; Tsukada S; Hashimoto S; Kunikata T; Arai S; Kurimoto M; Niida Y; Matsuoka H; Sakiyama Y; Iwata T; Tsuchiya S; Tatsuzawa O; Yoshizaki K; Kishimoto T
Blood; 1998 Jan; 91(2):595-602. PubMed ID: 9427714
[TBL] [Abstract][Full Text] [Related]
56. Clinical and Genetic Study of X-linked Agammaglobulinemia Patients (The Benefit of Early Diagnosis).
Alizadeh Z; Dashti P; Mazinani M; Nourizadeh M; Shakerian L; Tajik S; Movahedi M; Mamishi S; Pourpak Z; Fazlollahi MR
Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):305-309. PubMed ID: 32615664
[TBL] [Abstract][Full Text] [Related]
57. Characterization of novel Bruton's tyrosine kinase gene mutations in Central European patients with agammaglobulinemia.
Kristufek D; Aspalter RM; Eibl MM; Wolf HM
Mol Immunol; 2007 Mar; 44(7):1639-43. PubMed ID: 17045652
[TBL] [Abstract][Full Text] [Related]
58. Mutations in btk in patients with presumed X-linked agammaglobulinemia.
Conley ME; Mathias D; Treadaway J; Minegishi Y; Rohrer J
Am J Hum Genet; 1998 May; 62(5):1034-43. PubMed ID: 9545398
[TBL] [Abstract][Full Text] [Related]
59. Identification of mutations in the Bruton's tyrosine kinase gene, including a novel genomic rearrangements resulting in large deletion, in Korean X-linked agammaglobulinemia patients.
Jo EK; Wang Y; Kanegane H; Futatani T; Song CH; Park JK; Kim JS; Kim DS; Ahn KM; Lee SI; Park HJ; Hahn YS; Lee JH; Miyawaki T
J Hum Genet; 2003; 48(6):322-326. PubMed ID: 12768435
[TBL] [Abstract][Full Text] [Related]
60. Mutation of the BTK gene and clinical feature of X-linked agammaglobulinemia in mainland China.
Wang Y; Kanegane H; Wang X; Han X; Zhang Q; Zhao S; Yu Y; Wang J; Miyawaki T
J Clin Immunol; 2009 May; 29(3):352-6. PubMed ID: 19039656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
